EUVIMEDEUVIMED entdecken
Open Access

Atherogenic lipoproteins associate with loss of glycemic control in youth-onset type 2 diabetes: Results from the TODAY study

Lorraine E Levitt Katz, Samuel S Gidding, James D Otvos, Kimberly L Drews, Fida Bacha, Steven Willi, Santica Marcovina, Siripoom McKay, Ruth S Weinstock, TODAY Study Group

Journal of Clinical Lipidology · 2025

DOI: 10.1016/j.jacl.2025.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2025. Verfasst von Lorraine E Levitt Katz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Philadelphia, Philadelphia, PA, USA (Drs Katz, Willi). Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Lipoproteins, Atherosclerosis, Glycemic Control. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Type 2 diabetes (T2D) in adolescents is associated with an unfavorable lipid profile, but lipoprotein particle subspecies and branched-chain amino acid (BCAA) data are scarce. OBJECTIVE: To evaluate lipoprotein particle distributions, lipoprotein insulin resistance index (LP-IR), and BCAA levels longitudinally and their relationships with sex, race/ethnicity, treatment, and loss of glycemic control in adolescents with youth-onset T2D. METHODS: Participants from the TODAY study (n = 348) had samples analyzed yearly for glycated hemoglobin and nuclear magnetic resonance lipoprotein and BCAA assessments. RESULTS: At baseline, participants with T2D were 13.7 years old with T2D, obesity, and from racial and ethnic minority groups (32.2% Non-Hispanic Black [NHB], 43.7% Hispanic). Smaller low-density lipoprotein (LDL) and larger very low-density lipoprotein (VLDL) sizes, higher high-density lipoprotein (HDL) particle number, and increased LP-IR score predicted worsening of glycemic control. LDL, HDL, and VLDL particle numbers increased over 3 years with weaker trends for decreasing LDL and HDL size. LP-IR and BCAA levels were higher longitudinally in those who lost glycemic control. Females had larger HDL size than males at baseline and throughout. NHBs had the largest LDL and HDL sizes, smaller VLDL size, and lower LP-IR and BCAA. CONCLUSION: These data in youth with T2D demonstrate a progressive atherogenic lipoprotein phenotype over 3 years. Increased LP-IR and BCAA are associated with worsening glycemic control and may be contributing to the premature development of atherosclerosis in youth with T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2LipoproteinsAtherosclerosisGlycemic ControlHumansFemaleMaleAdolescentInsulin ResistanceAmino Acids, Branched-ChainLongitudinal Studies

Stichwörter der Autor:innen

AdolescentsAtherosclerosisLipidsMetabolic syndromeTriglyceridesType 2 diabetes

Substanzen

LipoproteinsAmino Acids, Branched-Chain

Autor:innen und Institutionen

  • Children's Hospital of Philadelphia, Philadelphia, PA, USA (Drs Katz, Willi).
  • Geisinger Health, Danville, PA, USA (Dr Gidding).
  • National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA (Dr Otvos).
  • The Biostatistics Center, George Washington University, Rockville, MD, USA (Dr Drews). Electronic address: kimberly.drews@pbrc.edu.
  • Baylor College of Medicine, Houston, TX, USA (Drs Bacha, McKay).
  • University of Washington, Seattle, WA, USA (Dr Marcovina).

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health
  • Bristol-Myers Squibb
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • University of Oklahoma Health Sciences Center
  • Indian Health Service
  • Eli Lilly and Company

Zitieren

APA

Katz, L. E. L., Gidding, S. S., Otvos, J. D., Drews, K. L., Bacha, F., Willi, S., Marcovina, S., McKay, S., Weinstock, R. S., & TODAY Study Group (2025). Atherogenic lipoproteins associate with loss of glycemic control in youth-onset type 2 diabetes: Results from the TODAY study. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2025.01.005

Vancouver

Katz LEL, Gidding SS, Otvos JD, Drews KL, Bacha F, Willi S, et al. Atherogenic lipoproteins associate with loss of glycemic control in youth-onset type 2 diabetes: Results from the TODAY study. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.01.005

BibTeX
@article{Katz2025,
  author = {Katz, Lorraine E Levitt and Gidding, Samuel S and Otvos, James D and Drews, Kimberly L and Bacha, Fida and Willi, Steven and Marcovina, Santica and McKay, Siripoom and Weinstock, Ruth S and TODAY Study Group, TODAY Study Group},
  title = {Atherogenic lipoproteins associate with loss of glycemic control in youth-onset type 2 diabetes: Results from the TODAY study},
  journal = {Journal of Clinical Lipidology},
  year = {2025},
  doi = {10.1016/j.jacl.2025.01.005}
}
Kostenlos starten →